Medisol Placements Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 19-12-2024
- Paid Up Capital ₹ 2.10 M
as on 19-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Net Worth -139.50%
(FY 2020)
- Total Assets 0.30%
(FY 2020)
About Medisol Placements
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siju Sukumaran, Rajaneesh Radhakrishnan, and Sreekanth Jayakumari serve as directors at the Company.
- CIN/LLPIN
U74995KL2018PTC053970
- Company No.
053970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medisol Placements Private Limited offer?
Medisol Placements Private Limited offers a wide range of products and services, including Job Consultation Service, Recruitment Service.
Who are the key members and board of directors at Medisol Placements?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreekanth Jayakumari  | Managing Director | 10-Jul-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siju Sukumaran | Director | 10-Jul-2018 | Current |
| Rajaneesh Radhakrishnan | Director | 10-Jul-2018 | Current |
Financial Performance of Medisol Placements.
Medisol Placements Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 139.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medisol Placements?
Unlock access to Medisol Placements's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medisol Placements?
Medisol Placements has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisol Placements, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisol Placements's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
